SCHEMBL3144024

SCHEMBL3144024

CC1(C)CC(=O)CC(C)(C)N1Cc1ccc(Cl)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMPD2 Q01433 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
DRD2 P14416 2/20 0.39
DRD4 P21917 2/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
SIGMAR1 Q99720 1/20 0.38
ELANE P08246 1/20 0.38
GRM2 Q14416 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
ERCC1 P07992 1/20 0.36
ERCC4 Q92889 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10813336 0.84 ELANE (0.50) AMPD2ALDH1A1KMT2AMEN1SIGMAR1
SCHEMBL3140656 0.78 AMPD2 (0.37) AMPD2KDM4EALDH1A1DRD2DRD4
SCHEMBL11807403 0.78 KDM4E (0.46) AMPD2KDM4EALDH1A1SIGMAR1MAPT
SCHEMBL22069772 0.77 HSD11B1 (0.42) AMPD2KDM4EALDH1A1DRD2DRD4
SCHEMBL3136334 0.74 AMPD2 (0.39) AMPD2KDM4EALDH1A1DRD2DRD4
SCHEMBL15638318 0.70 GAA (0.32)
SCHEMBL10356860 0.68 KDM4E (0.34) KDM4EKMT2AMEN1ELANEMAPT
SCHEMBL25092478 0.67 CMA1 (0.47) KDM4EALDH1A1KMT2AMEN1SIGMAR1
SCHEMBL20705018 0.67 CMA1 (0.47) KDM4EALDH1A1KMT2AMEN1SIGMAR1
SCHEMBL16749123 0.66 SIGMAR1 (0.41) ALDH1A1DRD2DRD4SIGMAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081692-A1 Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma ASTRAZENECA AB (SE) 2010-04-01 US disclosed
EP-1945613-A1 NOVEL 1 -BENZYL-4-PIPERIDINAMINES THAT ARE USEFUL IN THE TREATMENT OF COPD AND ASTHMA AstraZeneca AB (SE) 2008-07-23 EP disclosed
WO-2007053082-A1 NOVEL 1 -BENZYL-4-PIPERIDINAMINES THAT ARE USEFUL IN THE TREATMENT OF COPD AND ASTHMA ASTRAZENECA AB (SE) 2007-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081692-A1 Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma CCR1, CCR4, CCR10 AMPD2 2117/4885KDM4E 1997/4885ALDH1A1 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.